Neurology & Neurosurgery → McArdle Disease / Glycogen Storage Disease V

Metabolic myopathy / glycogenosis pathway

McArdle Disease Treatment in Germany: PYGM Diagnosis, Exercise Planning & Rhabdomyolysis Prevention

Research McArdle disease care in Germany, including PYGM genetic confirmation, CK and metabolic exercise assessment, second-wind phenomenon, supervised activity planning, nutrition review and rhabdomyolysis prevention.

Neurogenetic pathwayMcArdle Disease / Glycogen Storage Disease VPhenotype → molecular diagnosis → lifelong surveillanceEditorial illustration · not diagnostic imaging
By Treat in Germany Editorial TeamSources reviewed: 2026-09-02Independent clinician review: not yet claimed
Short answer: McArdle disease (glycogen storage disease type V) is an autosomal-recessive metabolic myopathy caused by pathogenic variants in PYGM, which impair muscle glycogen breakdown. German neuromuscular and metabolic centers can review the characteristic history, CK, prior exercise testing and molecular results, confirm whether the phenotype fits McArdle disease and build a safe long-term activity and self-management plan. There is currently no causal therapy that restores muscle myophosphorylase. The main evidence-based strategy is disease-adapted regular physical activity, education about the second-wind phenomenon and warning signs, individualized nutrition advice and prevention of severe exertional rhabdomyolysis.

The exercise history is a major diagnostic clue

McArdle disease classically causes exercise intolerance, painful cramps, muscle stiffness or contractures during intense or sustained activity. Symptoms often date back to school sports even when the diagnosis is made much later. A careful history should also ask about severe post-exercise muscle pain and episodes of dark or cola-colored urine.

The second-wind phenomenon is particularly characteristic

Many patients notice that exercise becomes easier after a short pause or after several minutes of lower-intensity activity. The Bonn review describes this second-wind phenomenon as a highly characteristic shift toward greater reliance on aerobic energy sources. It can help distinguish McArdle disease from other causes of exercise intolerance, but it should still be interpreted together with the full clinical and genetic work-up.

PYGM genetic testing is central to confirmation

McArdle disease results from biallelic pathogenic PYGM variants. CK is often elevated, but a normal CK does not completely exclude the diagnosis. When the clinical pattern is suggestive, molecular testing is the preferred confirmation pathway; muscle MRI or biopsy is reserved for selected unresolved questions rather than used automatically in every patient.

Specialized exercise testing can support the work-up

Freiburg's myopathy diagnostics service explicitly evaluates suspected glycogen storage disease type V using exercise-based metabolic testing in collaboration with the neuromuscular clinic. The exact test protocol should be chosen by the specialist team because excessive or poorly supervised exertion can provoke painful contractures or rhabdomyolysis in susceptible patients.

There is no approved causal drug for McArdle disease

Current management is not based on enzyme replacement, immunotherapy or a one-time procedure. Specialist care focuses on understanding the altered muscle energy metabolism, preventing high-risk exertion, maintaining conditioning and treating complications when they occur. Experimental approaches should be separated clearly from established care.

Regular adapted aerobic activity is usually preferred to inactivity

The Bonn review emphasizes disease-adapted regular physical activity as the leading recommended intervention. Patients learn to warm up gradually, recognize early pain and contracture signals, use the second-wind phase and avoid prolonged maximal or isometric effort. Exercise prescriptions should be individualized to baseline fitness, previous rhabdomyolysis and other medical conditions.

Nutrition advice should be individualized rather than sold as a fixed diet

Targeted carbohydrate intake before planned activity and other dietary strategies are sometimes discussed in McArdle disease, but there is no universal commercial diet package. A metabolic or nutrition team should consider activity pattern, body weight, diabetes risk, previous symptoms and the evidence for the specific strategy before recommending long-term dietary changes.

Rhabdomyolysis is the key acute safety issue

Severe exertion can cause muscle breakdown, dark urine and acute kidney injury. New dark or cola-colored urine after exertion, marked muscle swelling, severe persistent pain, reduced urine output or systemic illness requires prompt local medical assessment rather than waiting for planned travel to Germany. The aim of specialist follow-up is prevention and early recognition of these episodes.

A stable McArdle diagnosis usually needs long-term self-management, not repeated hospital procedures

After confirmation, the most useful German second opinion may be a focused review of exercise strategy, previous rhabdomyolysis, occupational demands, nutrition and questions about safe training. Much of the long-term follow-up can then continue locally with periodic specialist input.

What to send for a German McArdle second opinion

Send the records that show both the molecular diagnosis and the real-world exercise phenotype.

  • Complete PYGM genetic report, including zygosity and variant classification
  • Neuromuscular or metabolic specialist reports
  • Baseline and post-event CK results if available
  • Records of rhabdomyolysis, kidney injury or emergency visits
  • Previous exercise, lactate or metabolic testing reports
  • Muscle MRI or biopsy reports if already performed
  • Current exercise routine and activities that reliably trigger symptoms
  • Dietary strategies or pre-exercise carbohydrate use already tried
  • Current medications and relevant comorbidities
  • A specific question: confirm diagnosis, review exercise safety, prevent rhabdomyolysis, optimize nutrition or plan follow-up

Official sources

Sources last checked 2026-09-02. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.

Medical information notice: This page provides general educational information and does not diagnose disease or recommend an individual operation. Urgent neurological symptoms require timely local medical assessment.
Verified centers

German centers documenting this service

These are not rankings or paid recommendations. Centers are displayed alphabetically by city and are included because their official websites document the relevant treatment, diagnostic test or specialist program. Availability for an individual patient still requires clinical review.

University Hospital Bonn – Neuromuscular Center / Rare Disease Center

Bonn · Bonn's neuromuscular and rare-disease teams publish a dedicated McArdle clinical review describing PYGM genetics, second-wind phenomenon, CK/genetic confirmation, rhabdomyolysis risk and long-term exercise/self-management, and identify the Bonn Neuromuscular Center as a specialist point of care.

University Medical Center Freiburg – Myopathy Diagnostics / Neuromuscular Clinic

Freiburg · Freiburg explicitly lists glycogen storage disease type V (McArdle) among the metabolic myopathies evaluated by its exercise-based myopathy diagnostics service, working together with the Neuromuscular Clinic.

Heidelberg University Hospital – Adult Inherited Metabolic Disease Clinic

Heidelberg · Heidelberg's adult inherited metabolic disease clinic explicitly treats carbohydrate-metabolism disorders including glycogenoses and provides a structured transition and metabolic-medicine pathway for adults with inherited metabolic disease.

Browse verified centers → · Cost guide →

Related treatment research

More Neurology & Neurosurgery guides

Compare related procedures and diagnostic pathways before narrowing the hospital search. These links are educational and do not imply that one option is appropriate for an individual patient.

Send treatment request